Cervical Cancer (Screening)

FDA Approves ThinPrep Test as More Effective Than Pap Smear

Published in Women's Health Weekly, November 18th, 1996

Cytyc Corp., Boxborough, Massachusetts, announced that the U.S. Food and Drug Administration (FDA) approved the claim that ThinPrep Pap Test has been more effective than the Pap smear method of screening women for cervical cancer.

This is the first time the FDA has allowed a company to claim its product is significantly more effective than the conventional Pap smear. The FDA further confirmed that the quality of the cervical specimens prepared on Cytyc's ThinPrep System is significantly improved over that of the conventional Pap smear.

In May 1996, the FDA approved the ThinPrep Pap Test as a replacement for the conventional Pap smear method. "At...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry